SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $196,000 | -23.1% | 1,000 | -33.3% | 0.02% | -27.6% |
Q2 2020 | $255,000 | +100.8% | 1,500 | +36.4% | 0.03% | +61.1% |
Q1 2020 | $127,000 | +0.8% | 1,100 | 0.0% | 0.02% | +20.0% |
Q4 2019 | $126,000 | +48.2% | 1,100 | +10.0% | 0.02% | +50.0% |
Q3 2019 | $85,000 | +23.2% | 1,000 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $69,000 | -5.5% | 1,000 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $73,000 | +28.1% | 1,000 | 0.0% | 0.01% | +11.1% |
Q4 2018 | $57,000 | -26.0% | 1,000 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $77,000 | -38.9% | 1,000 | -47.4% | 0.01% | -18.2% |
Q2 2018 | $126,000 | +27.3% | 1,900 | 0.0% | 0.01% | +10.0% |
Q1 2018 | $99,000 | -2.9% | 1,900 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $102,000 | -1.0% | 1,900 | 0.0% | 0.01% | +11.1% |
Q3 2017 | $103,000 | +5.1% | 1,900 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $98,000 | -17.6% | 1,900 | 0.0% | 0.01% | -18.2% |
Q1 2017 | $119,000 | – | 1,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |